Business View Magazine Jan-2019

163 now, I think life expectancy will morph out another year or two. People born in 2023 will probably live a hundred years unless they’re killed in an accident or through some other unfortunate event. So,we’re getting better and better in our scientific approach.” BVM: Any final thoughts you’d like to leave with our readers? LeDoux: “We have a history, over the last 70 to 80 years in our country, of attacking symptoms versus attacking root causes and as the science evolves and companies like us and our colleagues make investments in the research,we’re going to start un- locking some of the mysteries of why things happen the way they do.As long as we maintain our heads about us and apply the scientific method,we’re going to be at the table with those seminal discus- sions that take place inWashington and elsewhere about what healthcare will look like 20 or 30 years from now.Are we part of the solution to explosive healthcare costs? I would humbly suggest, yes. “I also think that one of the reasons that people gravitate towards us is because the consumer is coming–not only in North America, but around the world.There’s been somewhat of a breach of trust that has taken place over the last several decades between companies that are saying,“Trust me, this is great,” and then the end result maybe being not so great.And the consumer,with access to the internet, access to information and research, is becoming much more knowledgeable,much more inquisi- tive, and justifiably skeptical. So, they’re doing their homework before theymake purchase decisions. And it’s incumbent for us to continue to make those appropriate investments in answering the questions that consumers have: Is this product beneficial for me and my family? What will it do? How does it work? And how can you make sure that the sources